| Code | 12663 | ||||||||||
| MA number | 44/0463/97-S | ||||||||||
| Product Form: | sol ijf 1x5 ml/10 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous and intravesical use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 23.10.1997 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Doxorubicin Sandoz 2 mg_ml_08.2023.pdf
|
| PIL: |
PIL_Doxorubicin Sandoz 2 mg_ml_08.2023.pdf
|
| Safety feature | Yes |
| Data update: | 23.03.2021 |
